Although proponents of government price caps on essential prescription drugs argue that such measures are vital to protect low-income patients from exorbitant healthcare costs, economic analysts point out that artificial price ceilings drastically reduce the projected revenue from newly developed therapies. Consequently, pharmaceutical companies will inevitably divert their funding away from high-risk, groundbreaking drug discovery toward safer, incremental modifications of existing medications. Because long-term therapeutic progress relies fundamentally on pioneering research rather than minor product iterations, implementing strict price caps on prescription drugs will ultimately undermine public health outcomes.
Which of the following best expresses the main conclusion of the argument?
- AGovernment price caps on essential prescription drugs are effective mechanisms for ensuring low-income patients can access necessary medical treatment.
- BArtificial price ceilings significantly lower the financial returns that drug companies expect to earn from developing new medical therapies.
- CPharmaceutical firms will respond to drug price controls by shifting research investments away from breakthrough discovery toward minor medicine modifications.
- Enacting strict government regulation on prescription drug prices will in the long run prove detrimental to overall public health.Answer
- EAbolishing price controls on prescription drugs would guarantee a rapid increase in the development of pioneering healthcare therapies.